Mark D. Roycik

Differentially Expressed Transcripts and Dysregulated Signaling Pathways and Networks in African American Breast Cancer

Paul A. Stewart, J. Alan Luks, Mark D. Roycik et al. · PLoS ONE · 2013 · 100 citations · Full text

Life Sciences, Genetics, Oncology +17

Coordinated peak expression of MMP-26 and TIMP-4 in preinvasive human prostate tumor

Seakwoo Lee, Kevin K. Desai, Kenneth A. Iczkowski et al. · Cell Research · 2006 · 56 citations

Medicine, Oncology, Urology +13

The Impact of Baseline Serum C-Reactive Protein and C-Reactive Protein Kinetics on the Prognosis of Metastatic Nasopharyngeal Carcinoma Patients Treated with Palliative Chemotherapy

Wei‐Xiong Xia, Yan‐Fang Ye, Xing Lü et al. · PLoS ONE · 2013 · 27 citations · Full text

Medicine, Oncology, Chemotherapy +14

Matrix Metalloproteinase Inhibitors Based on the 3-Mercaptopyrrolidine Core

Yonghao Jin, Mark D. Roycik, Dale B. Bosco et al. · Journal of Medicinal Chemistry · 2013 · 18 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

Genetic and cellular studies highlight that A Disintegrin and Metalloproteinase 19 is a protective biomarker in human prostate cancer

Gerard F. Hoyne, Caroline Rudnicka, Qing‐Xiang Amy Sang et al. · BMC Cancer · 2016 · 16 citations · Full text

Medicine, Molecular Biology, Oncology +8